Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record page for NCT02383927 now displays a 403 Forbidden error page instead of the usual study details, replacing content with a generic error screen. This indicates an access restriction or server-side issue preventing viewing the study record on ClinicalTrials.gov.SummaryDifference18%

- Check36 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a software release update rather than a modification to study data.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a software release rather than a change to the study content.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a small version update. This change does not modify the study information or content.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the study record metadata.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page displays a new revision tag, v3.6.2, replacing the previous v3.6.0, indicating an updated document version. This update does not reflect changes to study details or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.